BS_NR9FRY5T
Schwannoma
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- Schwannoma
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- Schwannoma
- age_years
- 7.797
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- INTERFERON_ALPHA_RESPONSE+0.619
- INTERFERON_GAMMA_RESPONSE+0.583
- TNFA_SIGNALING_VIA_NFKB+0.548
- ALLOGRAFT_REJECTION+0.491
- TGF_BETA_SIGNALING+0.457
- ANDROGEN_RESPONSE+0.431
- MYC_TARGETS_V1+0.422
- APOPTOSIS+0.406
- PROTEIN_SECRETION+0.405
- IL6_JAK_STAT3_SIGNALING+0.402
Top 10 suppressed
- PANCREAS_BETA_CELLS-0.351
- SPERMATOGENESIS-0.338
- HEDGEHOG_SIGNALING-0.252
- KRAS_SIGNALING_DN-0.242
- E2F_TARGETS-0.171
- NOTCH_SIGNALING-0.096
- G2M_CHECKPOINT-0.073
- WNT_BETA_CATENIN_SIGNALING-0.042
- GLYCOLYSIS-0.027
- MYOGENESIS-0.004
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | BS_H3Y8FWHV | Schwannoma | — | 0.936 |
| 2 | BS_JK0VPG1T | Schwannoma | — | 0.930 |
| 3 | BS_CQEETJ66 | Schwannoma | — | 0.926 |
| 4 | SRR12696731 | — | — | 0.904 |
| 5 | E5FB107A-9555-419F-84BF-2A59873104B9 | — | — | 0.903 |
| 6 | CB1F8B9C-7CE7-4181-B746-7FC697ED27F4 | — | — | 0.902 |
| 7 | BS_HBJZR69P | Schwannoma | — | 0.897 |
| 8 | SRR1410783 | GTEX | — | 0.895 |
| 9 | SRR934811 | — | — | 0.895 |
| 10 | BS_RR12T74P | Schwannoma | — | 0.893 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 40 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| INTERFERON_ALPHA_RESPONSE | 0.619 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.583 | Idelalisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.548 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.491 | Idelalisib | — uncovered |
| TGF_BETA_SIGNALING | 0.457 | Inavolisib | — uncovered |
| ANDROGEN_RESPONSE | 0.431 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.422 | Inavolisib | — uncovered |
| APOPTOSIS | 0.406 | Idelalisib | — uncovered |
| PROTEIN_SECRETION | 0.405 | Remibrutinib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.402 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.397 | Idelalisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.392 | Idelalisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.369 | Idelalisib | — uncovered |
| COMPLEMENT | 0.368 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.356 | Idelalisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.350 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.343 | Inavolisib | — uncovered |
| CHOLESTEROL_HOMEOSTASIS | 0.321 | Remibrutinib | — uncovered |
| MITOTIC_SPINDLE | 0.295 | Inavolisib | — uncovered |
| P53_PATHWAY | 0.290 | Idelalisib | — uncovered |